Final Programme - edtnaerca.org · Cannulation Devices across Europe and its Implications – The final result of an international Survey A joint project between EDTNA/ERCA & Medtronic

48th EDTNA/ERCA International ConferenceSeptember 14th-17th, 2019Prague, Czech Republic

Conference ThemeNew Pathways in the Renal Setting-Caring Together by Integrating Modern Technology based on Knowledge & Education

Final Programme

2

CONTENTWelcome Message from the President 3

Acknowledgement – Corporate Members 4

Acknowledgement – Conference Support 5

EDTNA/ERCA Booth 6

Conference Accreditation 6

The Conference Application – Instructions and Logistics 7

Conference Venue – Floor plans 8

Programme at a Glance 9

Scientific Programme Highlights 11

Scientific Programme 14

List of E-Posters 24

The Exhibition Floor Plan 30

The Exhibitors 31

Practical Conference Information 36

Opening Hours Summary 38

Good to know about Prague 38

Conference Contacts 39

3

WELCOME MESSAGE FROM THE PRESIDENT Dear Colleagues,We are very happy to welcome you to Prague for the 48th EDTNA/ERCA Conference. Last time the Conference was held in Prague was in 2008, now, 11 years later we are back in Prague.

The Scientific Programme is well prepared and there will be several Workshops, Educational Sessions and Poster sessions. New this year are the Courses which will be interactive sessions allowing everybody to share their expertise.

We are, as an Association, in the forefront of Online Communication and it has been a focus for some years and will continue to be one of our focuses for the coming years. Take the opportunity to download the Conference App. It works both for iPhones and Androids.

We should never forget that face to face meetings gives us so much more than just to be in a Video call. It has an important role of educating, exchanging information and experience, utilizing the expertise of all of us i.e. health care professionals, service leaders, academics, researchers, care givers, people with renal disease and industry partners.

Take this opportunity being at the Conference, to share experience with other delegates from around the world focusing on Chronic Kidney Disease.

Together, let’s make this Conference into another EDTNA/ERCA success. Welcome to the 48th EDTNA/ERCA International Conference in Prague!

With very warm regards,

Edita NoruisieneEDTNA/ERCA President

4

ACKNOWLEDGEMENT – CORPORATE MEMBERSOur Partners’ support, involvement and advice are greatly appreciated. Together we live and act according to our Mission and Vision and we are continuously working on achieving a high level of quality care for patients and their families. Being a Corporate Member sharing the key values, visions and missions of EDTNA/ERCA means that you are a very important part of the EDTNA/ERCA Community. Thank you for your continuous support.

5

ACKNOWLEDGEMENT – CONFERENCE SUPPORTWe would like to express our appreciation for the valuable support our Industry Partners’ bring by participating at the 48th EDTNA/ERCA International Conference. Our Partners support, involvement and advice are greatly appreciated. Thank You very much!

6

EDTNA/ERCA BOOTHDon’t miss the opportunity to visit the EDTNA/ERCA booth located in the Exhibition Area. There will be a lot of opportunities for you to share your experience and knowledge with your friends and colleagues and learn more about our ongoing activities within the Association. Talk to our Volunteers who will share with you the work that they have achieved during the year. The EDTNA/ERCA Brand Ambassadors will be more than happy to help you with any language problems which might occur.

Two new Educational Books will be available for you to pick up at the Booth.

Bring the vouchers included in the Conference Bag.

WELCOME!

CONFERENCE ACCREDITATIONAccreditation of Learning Hours The 48th EDTNA/ERCA International Conference in Prague is accredited. To ensure maximum quality in education and a professional Scientific Programme, EDTNA/ERCA has been granted International Continuing Nursing Education Credits (ICNEC) for the International Conference in Prague. The ICNEC are granted by the International Council of Nurses once strict admission conditions are fulfilled.

Participants of the conference will be awarded a maximum of 18 ICNECs. 1 credit is assigned for each 60minutes pent within the session halls, this is flexible and allows delegates to change between sessions and continue to accumulate credited time.

Please, note that not all sessions and workshops are accredited by ICN. If you are interested in receiving ICN credits, please see below the list of sessions not included in the accreditati on process: • S 02 Opening Ceremony• S 03 Corporate Education Session• S 08 Round Table Session – Empower PD Patients to Shared Care• W 04 Empower PD Patients to Self-Care – Validate patient´s skills to perform PD• Annual General Meeting 2019• W 07 Workshop – Gaining EDTNA/ERCA Accreditation for your Renal Education Program – What’s Involved• W 08 Workshop – Home Hemodialysis – Getting a better quality of life for your patients• S 25 Closing Ceremony

Certificate The ICNEC certificate is granted by the ICN and requires an Attendance Verification Form. This Form is available at the Registration desk during the Conference and it is to be completed (address and email) and signed by the delegate and should be returned to the Registration staff. A Certificate detailing the number of credits achieved will be provided after the Conference by ICN.

A Certificate of Attendance will be provided by the Registration desk on the final day of the Conference as usual, or you can apply via email at [email protected] until November 30th, 2019.

48th EDTNA/ERCA International ConferencePrague, Czech Republic, September 14th - 17th, 2019

-

EditorsAnastasia LiossatouMaria Cruz Casal

A Guide for Nurses

Caring for Patients with Polycystic Kidney Disease

Get your copy of the

book by visiting the

EDTNA/ERCA stand and

presenting this voucher

New Book

7

THE CONFERENCE APPLICATION – INSTRUCTIONS & LOGISTICS With the EDTNA/ERCA 2019 Conference App, you will have the opportunity to increase your interactivity and have the entire conference “in your hand”.

So, take advantage and download the App! Get the latest information and enhance your conference experience.

The EDTNA/ERCA 2019 Conference App gives access to:• Scientific Programme• Personal Planner / Congress Schedule • Venue Information• List of Posters• Exhibitors ... and much more!

Please follow the instructions to install the Conference Application on your mobile.

iPhone/Android – Go to the Appstore or Google play and download the Application. Name of the Application: EDTNA/ERCA 2019 If you have any difficulties in downloading the App or have any problems or questions about how to use it, please visit the EDTNA/ERCA booth and our EDTNA/ERCA Colleagues will support you.

BEST E-POSTER AND BEST SPEAKER VOTED BY THE DELEGATES!Last year we have successfully implemented the Best E-Poster Award voted by the Delegates.

This year we have implemented a new award – Best Speaker Award!

The rating will be done by You – our Conference Delegate and it is up to you whom to give the Award to. It is available for all Conference participants via the Conference Application. Use the star rating to vote for the best E-Poster or for the best speaker.

Both awards according to the conference delegates evaluation will be presented during the Closing Ceremony.

Don’t miss out the chance to influence!

8

CONFERENCE VENUE – FLOOR PLANS

9

PROGRAMME AT A GLANCE

Saturday, September 14th, 2019 08:00–16:00 16:00–17:45 17:45–18:00 18:00-19:30 19:30-21:45

Registration Area Registration

Hall A1+A2 S 01 Plenary Session Coffee break S 02 Opening Ceremony

Welcome & Exhibition Opening

Exhibition Area Exhibition

Sunday, September 15th, 2019 08:00–09:00 09:00–10:30 10:30–11:00 11:00–12:30 12:30–14:00 14:00–15:30 15:30–16:00 16:00–16:45 16:45–17:00 17:00–18:30


Hall A1

S 03 CES* – Fresenius Medical Care

The Future of Renal Nursing: Patient

Centered Care in the Digital Era

Coffee break S 05 DOPPS Clinical Symposium

Update from the DOPPS Program:

Centering care around patients

S 07 Polish Symposium12:45–13:45

S 09 Parallel SessionHaemodialysis 1

Coffee break S 11 Parallel SessionTransplantation

Break Annual General Meeting 2019

Hall A2

S 04 Parallel SessionEducation

S 06 Parallel SessionThe Patient Experience

S 08 Round Table Session – Baxter

Empower PD Patients to Shared Care

12:45–13:45

S 10 Parallel SessionHome Therapies

S 12 Parallel SessionOpen Forum 1

Hall A3

W 01 WorkshopDeveloping and

Maintaining Effective Teams

Lunch break W 02 WorkshopHuman Factors

and Patient Safety: Everybody’s Business

Hall B

W 03 WorkshopInvolving patients and family members from BAME/poor reached

communities in clinical research

Tower

C 01 CourseHygiene, Infection

Control and Prevention in Renal

Care14:00–14:45

C 02 CourseHygiene, Infection

Control and Prevention in Renal

Care


10

Monday, September 16th, 2019 08:00–09:00 09:00–10:30 10:30–11:00 11:00–12:30 12:30–14:00 14:00–15:30 15:30–16:00 16:00–17:30 17:30–18:00


Hall A1

S 13 Parallel SessionNeedling with Plastic Cannulae & Vascular

Access

Coffee break S 15 Parallel SessionVascular Access

Lunch break S 18 Parallel SessionHaemodialysis 2

Coffee break S 21 Parallel SessionEthical, Psychological

and Social Impact of CKD

Hall A2

S 14 Parallel SessionEuropean Kidney Health Alliance

S 16 Parallel SessionPeritoneal Dialysis

S 17 Greek ForumHypertension in Chronic Kidney

Disease12:45–13:45

S 19 Parallel SessionCaring for the Well-being of

Renal Healthcare Professionals

S 22 Parallel SessionOpen Forum 2

Hall A3

W 04 Workshop Empower PD patients to Self-Care – Validate

patient´s skills to perform PD

W 06 WorkshopUncovering the power

of extra-ordinary leadership – The

leadership Challenge

Lunch break W 08 Workshop – Physidia

Why opt for daily Home Haemodialysis?

12:45–13:45

Hall B

W 05 WorkshopAn Introduction to

Mindfulness Practices: Managing Stress and

Anxiety

W 07 WorkshopGaining EDTNA/ERCA

Accreditation for your Renal Education

Program – What’s Involved

12:45–13:45

S 20 Parallel Session Join session

ANNA-EDTNA/ERCA

Tower 1 E-Poster Session A E-Poster Session B Lunch break E-Poster Session C E-Poster Session D

Tower 2 C 04 Course

Violence & Aggression in Renal Care

C 06 CourseViolence & Aggression

in Renal Care

Aesculap Academy

C 03 CourseCritical states during a dialysis treatment

C 05 CourseCritical states during a dialysis treatment


Tuesday, September 17th, 201908:30–10:00 10:00–10:15 10:15–11:45 11:45–12:00 12:00–13:00 13:00–14:00


Hall A1S 23 Plenary SessionCKD & Conservative

Renal Care

Coffee break S 24 Plenary SessionRisk Management

Break S 25 Closing Ceremony

11

SCIENTIFIC PROGRAMME HIGHLIGHTSSCIENTIFIC PARALLEL SESSIONSInvited Guest Speakers discuss the latest developments in renal care during the plenary sessions. Quality Abstracts including the Short orals presentations have been selected for inclusion in the parallel sessions.

S 02 Opening Ceremony ImprovingPatientOutcomesThroughImplementationScience:AnImportantGoalinRenalCare John Sedgewick (United Kingdom)

S06 ThePatientExperience Engagingthe“poorlyreached”inkidneyresearchandawarenesscampaigns Neerja Jain (United Kingdom)

S14 EuropeanKidneyHealthAlliance ImprovingthelifeofkidneydiseasepatientsthroughoutEuropeandtheEU:theEuropeanKidneyHealthAlliance Raymond Vanholder (Belgium)

S23 CKD&ConservativeRenalCare TheOlderDialysisPatient:IssuesandConcerns Alice Hellebrand (United States)

LUNCHTIMESYMPOSIA

S07 PolishSymposium Vaccinationinhemodialyzedpatients Anna Klis (Poland)

Co-morbidityinhemodialyzedpatientsasanimportantaspectofnursingcare Małgorzata Liber (Poland) Elżbieta Cepuchowicz (Poland)

Nephrologicalnursesandoccupationalexposure–how?when?why? Aneta Trzcinska (Poland)

S17 GreekForum HypertensioninChronicKidneyDisease Vassilios Liakopoulos (Greece)

BloodPressuremeasurement–techniquedata Marianna Eleftheroudi (Greece)

WORKSHOPS&ROUNDTABLESESSIONS

W01 Workshop DevelopingandMaintainingEffectiveTeams John Sedgewick (United Kingdom)

W02 Workshop HumanFactorsandPatientSafety:Everybody’sBusiness Lesley Bennet (United Kingdom) Karen Jenkins (United Kingdom)

W03 Workshop InvolvingpatientsandfamilymembersfromBAME/poorreachedcommunitiesinclinicalresearch Neerja Jain (United Kingdom)

12

W04 Workshop

EmpowerPDpatientstoSelf-Care–Validatepatient´sskillstoperformPD Maria Arminda Tavares (Portugal)

W05 Workshop AnIntroductiontoMindfulnessPractices:ManagingStressandAnxiety Clare McVeigh (United Kingdom)

W06 Workshop Uncoveringthepowerofextra-ordinaryleadership–TheleadershipChallenge John Sedgewick (United Kingdom)

W07 Workshop GainingEDTNA/ERCAAccreditationforyourRenalEducationProgram–What’sInvolved John Sedgewick (United Kingdom) Theodora Khafkia (Germany)

W08 Workshop–Physidia

HomeHaemodialysis–Gettingabetterqualityoflifeforyourpatients Aziz Abercane (France) Veliana Todorova (France), Matt Willans (United Kingdom) Greig Johnstone (United Kingdom) Cedric Poulard, Physidia (France) Fredrik Thibblin (Sweden)

S08 RoundTableSession–Baxter

EmpowerPDpatientstoSharedCare DoctorsPerspective Thierry Lobbedez (France)

NursesPerspective Gail McMullan (United Kingdom)

ThePerspectiveoftheMultidisciplinaryTeam Maria Arminda Tavares (Portugal) Gail McMullan (United Kingdom) Aase Riemann (The Netherlands) Kalliopi-Anna Poulia (Greece) Mike Kelly (Belgium) Thierry Lobbedez (France)

13

COURSES

C 01; C 02 Course Hygiene,InfectionControlandPreventioninRenalCare Paul Challinor (United Kingdom) Ivana Bartakova (Czech Republic)

C03;C05 Course Criticalstatesduringadialysistreatment Michael Stern (Czech Republic)

C04;C06 Course Violence&AggressioninRenalCare Jaroslav Pekara (Czech Republic)

CORPORATEEDUCATIONSESSION

S03 CorporateEducationSession–FreseniusMedicalCare

TheFutureofRenalNursing:PatientCenteredCareintheDigitalEra Maria Teresa Parisotto (Germany) Ivana Lupomeska (Czech Republic) Raquel Ribeiro (Portugal) Marjelka Trkulja (Croatia) Niklas Best (Germany)

DOPPSSYMPOSIUM

S05 DOPPSClinicalSymposium

UpdatefromtheDOPPSProgram:Centeringcarearoundpatients Anna Marti i Monros (Spain) Michel Roden (Belgium) Marisa Pegoraro (Italy) Jennie King (United Kingdom)

14

SCIENTIFIC PROGRAMME

Saturday, September 14th, 201916:00–17:45 Hall A1 + A2

S 01 Plenary SessionThe EDTNA/ERCA Collaboration Program – Creating a long-term sustainable Association together with the Multidisciplinary TeamChairs: Edita Noruisiene, EDTNA/ERCA President (Lithuania) Anki Davidson, EDTNA/ERCA Marketing Director (Sweden)

Awareness, understanding and treatment practices among health care professionals involved in managing cachexia in patients with end-stage renal diseaseA joint project between EDTNA/ERCA Research Group & Queen’s University, Belfast (UK)Ilaria de Barbieri, EDTNA/ERCA (Italy)

Assessment for Malnutrition – Subjective Global Assessment (SGA) for dialysis patientsA joint project between EDTNA/ERCA & B. BraunMartin Meier, B. Braun (Germany)Kalliopi-Anna Poulia, EDTNA/ERCA (Greece)

Home Haemodialysis – From the Patient PerspectiveA joint project between EDTNA/ERCA & NxStageSiobhan Gladding, NxStage (United Kingdom)Henning Sondergaard, (Denmark)

Venous Needle Dislodgement – Is it necessary to report?A joint project between EDTNA/ERCA & Redsense MedicalSebastien Bollue, Redsense Medical (Sweden)Tai Mooi Ho Wong, EDTNA/ERCA (Spain)

Cannulation Devices across Europe and its Implications – The final result of an international SurveyA joint project between EDTNA/ERCA & MedtronicAndy Cox, Medtronic (United Kingdom)Maria Teresa Parisotto, EDTNA/ERCA (Germany)

17:45–18:00 Coffee break – Saturday, September 14th, 2019

18:00–19:30 S 02 Opening CeremonyConférencier and Master of the Opening Ceremony: Ilaria de Barbieri, (Italy)

Guest Speaker lecture Improving Patient Outcomes Through Implementation Science: An Important Goal in Renal CareJohn Sedgewick (United Kingdom)

19:30 Welcome & Exhibition Opening

Saturday Sunday Monday Tuesday

15

Sunday, September 15th, 201909:00–10:30 Hall A1 Hall A2

S 03 Corporate Education Session – Fresenius Medical CareThe Future of Renal Nursing: Patient Centered Care in the Digital EraChair: Raquel Ribeiro (Portugal)

S 04 Parallel SessionEducationChairs: John Sedgewick (United Kingdom) & Nicola Thomas (United Kingdom)

Holistic care yesterday, today and tomorrow in renal nursingMaria Teresa Parisotto (Germany)

O 01Post test evaluation of a patient decision aid with decision coaching for dialysis choiceJeanette Finderup (Denmark)

The power of information in the digital nursing eraIvana Lupomeska (Czech Republic)

O 02Importance of an educational program in the control of hyperphosphatemiaMárcia Cuba (Portugal)

Digital opportunities to improve patient careNiklas Best (Germany)

O 03Investigation of factors affecting dialysis technician students’ learning styles and attitudes towards technologyFatma Kaban (Turkey)

Translating digital opportunities into improved patient careRaquel Ribeiro (Portugal)

O 04An innovative pathway: community, local authority & charity partnership addresses barriers to organ donationNeerja Jain (United Kingdom)

Empowering renal nurses for the futureMarjelka Trkulja (Croatia)

SO 05Management of urinary tract infections in dialysis patient- A case studyDavid Meshman (Israel)

Discussion panel SO 06Educational and follow up program for dialysis patients’ treatment outcomesJoão Pedro Barros (Portugal)

SO 07National audit of dialysis units in the Kingdom of Saudi ArabiaReem Alhameedi (Saudi Arabia)

10:30–11:00 Coffee break – Sunday, September 15th, 2019


16

11:00–12:30 Hall A1 Hall A2 Hall A3

S 05 DOPPS Clinical SymposiumUpdate from the DOPPS Program: Centering care around patientsChairs: Edita Noruisiene (Lithuania) & Anna Marti i Monros (Spain)

S 06 Parallel SessionThe Patient ExperienceChairs: Mike Kelly (Ireland) & Karen Jenkins (United Kingdom)

W 01 WorkshopDeveloping and Maintaining Effective TeamsChair: John Sedgewick (United Kingdom)

Perceptions about the dialysis modality decision process among peritoneal dialysis and in-centre haemodialysis patientsAnna Marti i Monros (Spain)

Guest Speaker lectureEngaging the “poorly reached” in kidney research and awareness campaignsNeerja Jain (United Kingdom)

Coping with kidney disease – qualitative findings from the Empowering Patients on Choices for Renal Replacement Therapy (EPOCH-RRT) study Michel Roden (Belgium)

O 08Quality of life in haemodialysis and conservative management patientsClare McKeaveney (United Kingdom)

Patient perspectives on the choice of dialysis modality: Results from the Empowering Patients on Choices for Renal Replacement Therapy (EPOCH-RRT) study Marisa Pegoraro (Italy)

SO 10Evaluating patient and carer perspectives of a kidney supportive care programAnn Bonner (Australia)

Associations of self-reported physical activity types and levels with quality of life, depression symptoms, and mortality in haemodialysis patientsJennie King (United Kingdom)

SO 11Pain management using music therapy in a dialysis unitFlorence Fernandes (France)

Panel Discussion – All speakers and audience

SO 12Transplant education programme – patient experienceJuby Susan Thomas (Ireland)

12:30–14:00 Lunch break – Sunday, September 15th, 2019

Hall A1 Hall A2

S 07 Lunch SymposiumPolish Symposium12:45–13:45Chairs: Aneta Trzcinska (Poland) & Anna Klis (Poland)

S 08 Round Table Session – BaxterEmpower PD Patients to Shared Care12:45–13:45Chair: Maria Arminda Tavares (Portugal)

(Session in Polish language)Session WelcomeIlaria de Barbieri (Italy)

Vaccination in hemodialyzed patientsAnna Klis (Poland)

Co-morbidity in hemodialyzed patients as an important aspect of nursing careMałgorzata Liber (Poland)Elżbieta Cepuchowicz (Poland)

Nephrological nurses and occupational exposure – how? when? why?Aneta Trzcinska (Poland)

Doctors PerspectiveThierry Lobbedez (France)

Nurses PerspectiveGail McMullan (United Kingdom)

The Perspective of the Multidisciplinary TeamPanel Discussion: Maria Arminda Tavares (Portugal), Thierry Lobbedez (France), Gail McMullan (United Kingdom), Aase Riemann (The Netherlands), Kalliopi-Anna Poulia (Greece), Mike Kelly (Ireland)


17

14:00–15:30 Hall A1 Hall A2 Hall A3 Hall B Tower

S 09 Parallel SessionHaemodialysis 1Chairs: Susan Rogers (The Netherlands) & Hanadi Mezher (Lebanon)

S 10 Parallel SessionHome TherapiesChairs: Michael Roden (Belgium) & Linsey Worsey (United Kingdom)

W 02 WorkshopHuman Factors and Patient Safety: Everybody’s BusinessChairs: Lesley Bennet (United Kingdom)Karen Jenkins (United Kingdom)

W 03 WorkshopInvolving patients and family members from BAME/poor reached communities in clinical researchChair: Neerja Jain (United Kingdom)

C 01 CourseHygiene, Infection Control and Prevention in Renal Care14:00–14:45Lectors: Paul Challinor (United Kingdom) & Ivana Bartakova (Czech Republic)

O 13Quality of life, emotional states and pain in patients with chronic haemodialysis treatmentAfra Masià-Plana (Spain)

O 20Buttonhole in Daily Home Hemodialysis (DHHD): A rigorous practice for an optimal long-term resultFrancoise Delestre (France)

O 14Cachexia and end-stage renal disease: results from a cross-sectional analysisClare McKeaveney (United Kingdom)

O 21Nursing perception of the selection of existing hemodialysis patients for home therapiesJacqueline Cainglet (United Arab Emirates)

O 15Quality of life in the aspect of dental problems in haemodialysis patientsAnna Kliś (Poland)

O 22No site infection with buttohhole needling technique when implementing double anti-sepsia two years experienceAnna Marti i Monros (Spain)

O 16Intradialytic exercise and physical activity levels: effects beyond the dialysis period!Rui Sousa (Portugal)

O 23Improving care and overcoming barriers through learnings from our patients/familiesEthel Macatangay (Canada)

SO 17Does intravascular volume status measured by inferior vena cava ultrasound correlate with bioimpedance spectroscopy?Ulrich Steinwandel (Australia)

SO 24Sharing practices and standards to improve sustainability of home haemodialysis globally. SIGNhd Global.Laura Thompson (United Kingdom)

SO 18Measurement of vascular access flow and recirculation in chronic haemodialysis patientsErika Petrovic (Slovenia)

SO 25To overcome barriers for self needlingAnna Marti i Monros (Spain)

SO 26The Journey Home: Growing a home hemodialysis program while fostering professional relationshipsKathleen Brown (Canada)

15:30–16:00 Coffee break – Sunday, September 15th, 2019


18

16:00–16:45 Hall A1 Hall A2 Tower

S 11 Parallel SessionTransplantationChairs: Marie Richards (United Arab Emirates) & Stavroula Vovlianou (Greece)

S 12 Parallel SessionOpen Forum 1Chairs: Ilaria de Barbieri (Italy) & Veronica Strini (Italy)

C 02 CourseHygiene, Infection Control and Prevention in Renal Care Lectors: Paul Challinor (United Kingdom) & Ivana Bartakova (Czech Republic)

O 27Renal nurses’ perceptions regarding cadaveric ikdney transplantation in Abu DhabiMesele Emily Ralyona (United Arab Emirates)

O 31Nursing role in identification of patients at risk of Acute Kidney Injury in AbuDhabiMadeline Manuel (United Arab Emirates)

SO 29The phenomenon of urinary tract infection experienced by women with a kidney transplantLotte Løntoft Mathiesen (Denmark)

O 32Illness experience in nephrotic syndromeAnneli Jönsson (Sweden)

SO 30Evaluation of barriers to kidney transplantation in a dialysis unitRawia Badran (Israel)

O 33What do patients know and remember about their lives in hemodialysis? A multicentric studyDonato Leopaldi (Italy)

16:45–17:00 Break – Sunday, September 15th, 2019

17:00–18:30 Hall A1

Annual General Meeting 2019Chair: Edita Noruisiene (Lithuania)

Welcome by the President Agenda: IntroductionElectronic Voting explanation and test, Check for Quorum of MembersActivity Report 2018Financial Report 2018 Questions, Discussion and Approval MotionsEC Elections and EC Committee 2019 – 2020Reward and RecognitionStrategy 2019–2025Date and Venue of AGM 2020Closing


19

Monday, September 16th, 201909:00–10:30 Hall A1 Hall A2 Hall A3 Hall B Tower 1 Aesculap Academy

S 13 Parallel SessionNeedling with Plastic Cannulae & Vascular AccessChairs: Marianna Eleftheroudi (Greece) & Marisa Pegoraro (Italy)

S 14 Parallel SessionEuropean Kidney Health AllianceChairs: Alois Gorke (Germany) & Anna Klis (Poland)

W 04 Workshop – BaxterEmpower PD patients to Self-Care – Validate patient´s skills to perform PDChairs: Susan Rogers (The Netherlands) & Aase Riemann (The Netherlands)

W 05 WorkshopAn Introduction to Mindfulness Practices: Managing Stress and AnxietyChair: Clare McVeigh (United Kingdom)

E-Poster Session AChairs: Michael Roden (Belgium) & Aneta Trzcinska (Poland)

C 03 CourseCritical states during a dialysis treatmentLector: Michael Stern (Czech Republic)

O 34Analysis of the experience in the use of plastic needles in the Spanish-hemodialysis unitsGuillermo Pedreira-Robles (Spain)

Guest Speaker lectureImproving the life of kidney disease patients throughout Europe and the EU: the European Kidney Health AllianceRaymond Vanholder (Belgium)

Practical ModuleAll participants will be given an evaluation form based on Self-care model by Dorothea Orem, to assess patients’ skills to perform PD. The participating groups will be asked to give their opinion about the evaluation formMaria Arminda Tavares (Portugal)

E-P 001Psycho-physical well-being in therapeutic adherence in women with autosomal dominant polycystic kidney diseaseElena Brioni (Italy)

O 35Patients and nurses perspectives about plastic cannulae for arteriovenous fistulaRui Sousa (Portugal)

O 41Balanced program obesity reduction kidney disease conducted by a nurse specialized in physical activityAlícia Rovira (Spain)

Theoretical ModulePresenting guidelines and clinical evidence about PD patient education.Maria Arminda Tavares (Portugal)

E-P 003The phenomenon of the burnout in nurses working in hemodialysisAlessandro Pizzo (Italy)

O 36The nurse’s role in vascular access infection preventionPaula Cale (Portugal)

O 42New pathways– improving knowledge and education to barriers to organ donation and “opting out”Neerja Jain (United Kingdom)

E-P 004Intradialytic exercise and season variations in haemodialysis patientsRui Camisa (Portugal)

O 37Individualized cannulation technique centered to patient needsTânia Galhofas (Portugal)

O 43Younger people are also accessing kidney supportive careAnn Bonner (Australia)

E-P 005Individualized teaching to the dialysis patientCélia Cunha (Portugal)

SO 38Plastic versus metal cannulae in hemodialysisZorica Obric (Serbia)

SO 44The impact of Mediterranean Diet on biochemical markers and cardiovascular risk factors in CKDVasiliki Zoi (Greece)

E-P 006Patients self-care as promoter of quality of life: a case studyTânia Galhofas (Portugal)

SO 39How to obtain a database for a vascular access monitoring and surveillance programme?Milene Cruz (Portugal)

E-P 007Impact of an exercise program on physical and mental health of regular Hemodialysis patientsBoaventura Cabecinhas (Portugal)

SO 40Vascular surveillance program: 18 months resultsCatarina Santos Cunha (Portugal)

E-P 008Improvement on patient experience and outcome with HDx dialyzerBetty Choi (Canada)

E-P 009Impact of an intradialytic exercise program on body composition, phase angle and functional capacitySoraia Vieira (Portugal)

E-P 010Learning needs analysis: the 3rd surveyMarie Richards (United Arab Emirates)

10:30–11:00 Coffee break – Monday, September 16th, 2019


20

11:00–12:30 Hall A1 Hall A2 Hall A3 Tower 1 Tower 2 Aesculap Academy

S 15 Parallel SessionVascular AccessChairs: Ruben Iglesias (Spain) & Irmina Vaicekauskyte (Lithuania)

S 16 Parallel SessionPeritoneal DialysisChairs: Aase Riemann (The Netherlands) & Lynn Brown (Australia)

W 06 WorkshopUncovering the power of extra-ordinary leadership – The leadership ChallengeChair: John Sedgewick (United Kingdom)

E-Poster Session BChairs: Jeannette Finderup (Denmark) & Stavroula Vovlianou (Greece)

C 04 CourseViolence & Aggression in Renal CareLector: Jaroslav Pekara (Czech Republic)

C 05 CourseCritical states during a dialysis treatmentLector: Michael Stern (Czech Republic)

O 45Must cannulation technique minimizes cannulation site problemsRui Sousa (Portugal)

O 52What type of dialysis better to choose first?Rachel Morgenstern (Israel)

E-P 012Therapeutic compliance in haemodialysis patients. Can nurses improve it?Valerio Neiviller (Italy)

O 46Preventive care of distal ischemia related with haemodialysis vascular accessAndreia Silva (Portugal)

O 53Using UV-paint for evaluating touch-contamination of a patient-assistance device for peritoneal dialysisSandra Neumann (Switzerland)

E-P 014Online clearance monitoring (OCM Kt/V) vs. monthly laboratory Kt/V measurement in pediatric hemodialysis patientsAna Grilo (Qatar)

O 47High-flow vascular access: the impact on the patientElisa Amaral (Portugal)

O 54Successful peritoneal dialysis treatment despite abdominal adhesions (a case study)Iris Romach (Israel)

E-P 015Ambulatory blood pressure in hemodialysis patientsNopparat Maeboonruen (Thailand)

O 48Are prosthesis segment interpositions in arteriovenous fistula producing good outcomes?Elisa Amaral (Portugal)

SO 56Patient management in the vascular access failure: a case (emergency periton dialysis)Duygu Balci (Turkey)

E-P 016Dialysis disequilibrium syndrome in incremental hemodialysisNiramon Wongyai (Thailand)

SO 49Ultrasound monitoring of the buttonhole: creation of a classification and assessment of its effectivenessCarolina Rubiella Rubio (Spain)

SO 57An improved CAPD submodality using a new assist device: CAAPD (Continuous Ambulatory/Automated Peritoneal Dialysis)Turkan Sanli (Turkey)

E-P 018The relationship between burnout and organizational commitment among nurses working in nephrology departmentsMilana Haimovich (Israel)

SO 50Resistance to Chlorexidine as needling site antiseptic agent, and frequent useAnna Marti i Monros (Spain)

SO 58Adapting teaching and learning methodologies following a training needs analysisCathy Poole (United Kingdom)

E-P 020Brown tumor as complication of severe secondary hyperparathyroidism in hemodialysis patients: a case reportMahmoud Ikteelat (Israel)

SO 51Doing rope-ladder or bottonhole that’s the question?Lise Streubel-Kristensen (Denmark)

E-P 002Estimating the prevalence of muscle wasting, weakness and sarcopenia in haemodialysis patientsClare McKeaveney (United Kingdom)

12:30–14:00

Lunch break – Monday, September 16th, 2019

Hall A1 Hall A2 Hall A3 Hall B

S 17 Lunch SymposiumGreek Forum – Hypertension in Chronic Kidney Disease12:45-13:45Chairs: Panagiota Tsougia, President of HENNA & Vasiliki Lagazali, Secretary of HENNA & Stavroula Vovlianou (EDTNA/ERCA Brand Ambassador)

W 07 Workshop12:45-13:45Gaining EDTNA/ERCA Accreditation for your Renal Education Program – What’s InvolvedChairs: John Sedgewick (United Kingdom) & Theodora Kafkia (Greece)

(Session in Greek language)

Hypertension in Chronic Kidney DiseaseVassilios Liakopoulos (Greece)

Blood Pressure measurement – technique dataMarianna Eleftheroudi (Greece)


21

14:00–15:30 Hall A1 Hall A2 Hall A3 Hall B Tower 1 Tower 2

S 18 Parallel SessionHaemodialysis 2Chairs: Anna Marti i Monros (Spain) & Hanadi Mezher (Lebanon)

S 19 Parallel SessionCaring for the Well-being of Renal Healthcare ProfessionalsChairs: Maria Arminda Tavares (Portugal) & Jeannette Finderup (Denmark)

W 08 Workshop – PhysidiaHome Hemodialysis – Getting a better quality of life for your patientsChair: Irmina Vaicekauskyte (Lithuania)

S 20 Parallel SessionJoin session ANNA-EDTNA/ERCAVascular Access: an International PerspectiveChairs: Lynda K. Ball (ANNA Immediate Past President) & Maria Teresa Parisotto (EDTNA/ERCA Secretary)

E-Poster Session CChairs: Carlos Goncalves (Portugal) & Marie Richards (United Arab Emirates)

C 06 CourseViolence & Aggression in Renal CareLector: Jaroslav Pekara (Czech Republic)

O 59Investigation of comfort and some factors affecting patients with hemodialysis treatmentSafiye Yanmış (Turkey)

O 66Exploring renal nurses’ attitudes and views to a patient’s decision to refuse dialysis treatmentMike Kelly (Ireland)

Principle benefits of home hemodialysis for renal patientsVeliana Todorova (France)

E-P 013Transition of care – quality improvement project in a hospital-based dialysis unitIris Romach (Israel)

O 60Investigation of effect on daily life activities and symptoms in hemodialysis patientsMukadder Mollaoğlu (Turkey)

O 67The effect of working conditions on dialysis nurses’ health in GreeceChrysanthi Avrami (Greece)

Home hemodialysis – from the patient perspectiveAziz Abercane, Patient (France)

E-P 022Transhepatic catheter access: a case studyVirgínia Barroso Henriques (Portugal)

O 61Nurse led implementation of a safe and effective hemoglobin control protocol in hemodialysis patientsMichal Exman (Israel)

O 68Which factors influence the level of nursing job satisfaction on haemodialysis private units?Inês Agostinho (Portugal)

Home hemodialysis in practiceMatt Willans (United Kingdom)Greig Johnstone (United Kingdom)Cedric Poulard (France)Fredrik Thibblin (Sweden)

E-P 023The overhydration status of patients with arteriovenous graft thrombosisTelmo Carvalho (Portugal)

SO 62Nurses’ perspectives on patient participation in hemodialysis treatmentsChava Kurtz (Israel)

O 69Safety climate, safety behaviour and risk perception among nurses on dialysis unitsMário Mateus (Portugal)

E-P 024Physical examination of arteriovenous fistula: how are we doing it and how to improveOsvaldo Albuquerque (Portugal)

SO 63Exploring the concordance of malnutrition assessment tools with the GLIM criteria among hemodialysis patientsLiana Poulia (Greece)

SO 70Prevalence of musculoskeletal complaints among haemodialysis nursesMagnus Lindberg (Sweden)

E-P 025Development of nocturnal guidelines for home haemodialysis by special interest group for home haemodialysis (SIGNhd-UK)Laura Thompson (United Kingdom)

SO 64Systematic fluid assessment in haemodialysis care: Development and validation of a decision aidJenny Stenberg (Sweden)

SO 71Unchanged nursing caretime for patients undergoing haemodialysis despite changes in characteristics over four yearsRia de Kleijn (The Netherlands)

E-P 026The relationship between LVEF and renal function, blood pressure, albumin, hemoglobin in CKD patientsNihal Khatib (Israel)

SO 65The effect of patient compliance on the phosphorus level in bloodLyubov Kaurova (Russian Federation)

SO 72“My Chinese sister “ – Who takes care of the caregiver?Victoria Sura Zaslavski (Israel)

E-P 027Monitoring vascular access with indirect methodsSilvia Cappelletti (Italy)

E-P 028Usefulness of Stress Qb Test in vascular access surveillance. Results of a hemodialysis centerAna Catarina Brito Silva (Portugal)

E-P 030The use of an ultra-sound by nurses in Hemodialysis Unit: Benefits and LimitationsJoana Ramos (Portugal)

15:30–16:00 Coffee break – Monday, September 16th, 2019


22

16:00–17:30 Hall A1 Hall A2 Tower 1

S 21 Parallel SessionEthical, Psychological and Social Impact of CKDChairs: Anastasia Liossatou (Greece) & Silvija Vladislavic (Croatia)

S 22 Parallel SessionOpen Forum 2Chairs: Jeannette Finderup (Denmark) & Lynn Brown (Australia)

E-Poster Session DChairs: Linsey Worsey (United Kingdom) & Anna Klis (Poland)

O 73Feasibility of a randomised controlled trial of an arts-based intervention for patients receiving haemodialysisClaire Carswell (United Kingdom)

O 80“Outstanding patient” competition among dialysis patients to promote adherence to treatmentLea Michaelashvili (Israel)

E-P 031Patient Safety Culture in a Hemodialysis clinicAna Grilo (Qatar)

O 75Are chronic kidney disease patients happy people?Catarina Sanha Cunha (Portugal)

O 81Exploring the knowledge of non-renal nurses regarding the nursing management of in-patient hemodialysis patientsFreddie Costales (United Arab Emirates)

E-P 032How to re-incorporate nursing documentation in a new complex electronic healthcare recording systemAnne Marie Boeskov (Denmark)

SO 76“Hope” – a multidimensional concept in nursing careVirgínia Barroso Henriques (Portugal)

O 82Haemodialysis nurses’ confidence in carrying out a comprehensive renal physical assessment: a pilot projectJerel Kim Laguardia (United Arab Emirates)

E-P 033Factors influencing postural balance in haemodialysis patientsAna Lino (Portugal)

SO 77Quality of life of dialysis patients and treatment regime adherenceAna Sofia Gomes (Portugal)

O 83Nursing case manager in a haemodialysis unit: the way to improvePedro Gonçalves (Portugal)

E-P 034A review of comprehensive discharge planning to patients with new onset diabetes after transplantationGitte Marie Erdmann (Denmark)

SO 78Perception of the patients’ quality of life during the first year of dialysis treatmentCarina Gonçalves (Portugal)

SO 84Providing mindfulness meditation to patients with end stage kidney disease- overview of best practiceClare Mc Veigh (United Kingdom)

E-P 035Multidisciplinary treatment of a calciphylaxis injuryHugo Costa Azevedo (Spain)

SO 79Investigation of fatigue and some factors affecting patients with chronic kidney diseaseEsra Başer (Turkey)

SO 85Evaluation of the efficiency of hygiene and infection control trainings in hemodialysis centersFatma Kaban (Turkey)

E-P 036Benefits of Kidney transplant in frailty patientMaria Vera Casanova (Spain)

SO 86Timely referral to angioplasty due to arteriovenous fistula maturation failureTelmo Carvalho (Portugal)

E-P 037FMEA- small act can save – or cost – a lifeMuhammad Khaskiya (Israel)

E-P 038Nursing interventions to prevent infections in Peritoneal Dialysis patients – literature reviewMaria Arminda Tavares (Portugal)


23

Tuesday, September 17th, 201908:30–10:00 Hall A1

S 23 Plenary SessionCKD & Conservative Renal CareChairs: Evgenia Golland (Israel) & Reem Alhameedi (Saudi Arabia)

Guest Speaker lectureThe Older Dialysis Patient: Issues and ConcernsAlice Hellebrand (United States)

O 87Kidney supportive care: Evaluation of treatment decision-making and advance care plansAnn Bonner (Australia)

O 88Palliative care needs in chronical kidney disease on regular haemodialysis patientsTatiana Silva (Portugal)

SO 89Last days of hepatitis C virusPéter Kabai (Hungary)

SO 90Development and introduction of a mentorship learning program for renal nursesLynn Brown (Australia)

SO 91Psychosocial experiences of patients with end stage kidney disease: a phenomenological studyMiriam Carole Atieno Wagoro (Kenya)

10:00–10:15 Coffee break – Tuesday, September 17th, 2019

10:15–11:45 Hall A1

S 24 Plenary SessionRisk ManagementChairs: Tai Mooi Ho Wong (Spain) & Marisa Pegoraro (Italy)

O 92The effect of a balance exercise programme on haemodialysis patientsAna Furtado (Portugal)

O 93Factors influencing incidence of falls in haemodialysis patientsHugo Oliveira (Portugal)

SO 94Factors that influence the patient’s perception of safety during haemodialysisAna Catarina Pereira (Portugal)

SO 96Break the barriers on hand hygiene in a haemodialysis unitMarta Coimbra (Portugal)

SO 97Good practice guide to prevent dissemination of infection by Klebsiella pneumoniae-carbapenemase in haemodialysis centerEsmeralda Nunes (Portugal)

11:45–12:00 Break – Tuesday, September 17th, 2019

12:00–13:00 Hall A1

S 25 Closing CeremonyWelcome to the Closing CeremonyConference OverviewPoster Award voted by the Conference DelegatesSpeaker Award voted by the Conference DelegatesThe 49th EDTNA/ERCA International Conference, 2020Closing of the 48th EDTNA/ERCA Conference


24

LIST OF E-POSTERSConservative Renal Care E-P 041

Education E-P 042 – E-P 043; E-P 045 – E-P 049

Ethical, Psychological and Social Impact of CKD E-P 050

Haemodialysis E-P 051 – E-P 058; E-P 060 – E-P 062; E-P 064; E-P 103

Home Therapies E-P 065; E-P 104

Multimorbidity in Renal Care E-P 067

Nutrition E-P 072

Open Forum E-P 073 – E-P 076

Peadiatric Renal Care E-P 077

Peritoneal Dialysis E-P 078 – E-P 080; E-P 082 – E-P 083

Risk Management & Quality Improvement E-P 084 – E-P 088; E-P 091

The Patient Experience E-P 092 – E-P 094

Transplantation E-P 095 – E-P 099; E-P 101 – E-P 102

Vascular Access E-P 099 – E-P 102

25

CONSERVATIVE RENAL CARE

E-P 041 Renal nurse practitioner leadership in renal supportive careS. RussoNephrology, Hunter New England local health district, Newcastle, Australia

EDUCATION

E-P 042 Education and training: impact of phosphate binders complianceP. Alejandre Malda, M. Vicario Marquegui, F. J. Lopez Sanchez, J. Madarieta Juaristi, X. Perez Saenz Azkunaga, J. Sanchez JimenezNephrocare- Bilbao dialysis center (Dialbilbo), Bilbao, Spain

E-P 043 Using the spiral curriculum model to improve record keeping in satellite haemodialysis unitsC. Poole, C. Hutchinson, M. Starr, B. BrierleyTraining & Education, Fresenius Medical Care, Birmingham, United Kingdom

E-P 045 Applying strategy to promote, support and monitor improvements in hand hygiene compliance in haemodialysisG. Dewsnap, G. Cater, N. Ward, N. Beddows, C. PooleNephrocare Head Office, Fresenius Medical Care, Kings Norton, Birmingham, United Kingdom

E-P 046 Education and Decision Support for Unplanned Start PatientZ. Aydin1, S. Ozcan2

1Health Science Institute, Koc University, Istanbul, Turkey; 2Nursing Faculty, Koc University, Istanbul, Turkey

E-P 047 Evaluating the effectiveness of patient education methodsF. Kaban1, E. Dane2, D. Yalçın3, N. Burbut4, Ö. Usul4, B. Yılmaz4, H. Kaptanogulları5

1Training Coordinator, Vocational School of Health Services- Dialysis Department, Lecturer, Medikare Dialysis Centers, Biruni University, Istanbul, Turkey; 2Vocational School of Health Services- Dialysis Department, Lecturer, Acibadem University, Istanbul, Turkey; 3Vocational School of Health Services- Dialysis Department, Lecturer, Istanbul Bilim University, Istanbul, Turkey; 4Registered Mentor Nurse, Medikare Dialysis Centers, Istanbul, Turkey; 5Chairman-Vocational School of Health Services- Dialysis Department, Academic member, Medikare Dialysis Centers, Biruni University, İstanbul, Turkey

E-P 048 Development of a patient education system in our dialysis clinicT. FarkasDialysis Centre, Fresenius Medical Care, Sátoraljaújhely, Hungary

E-P 049 Training for daily home hemodialysis – psychological aspects

F. Delestre, C. MontetNephrologie et Dialyses, Hopital Tenon, Paris, France

ETHICAL, PSYCHOLOGICAL AND SOCIAL IMPACT OF CKD

E-P 050 Where do you perform your CAPD exchange?S. VladislavicDepartment of nephrology and hemodialysis, University Hospital Split, Split, Croatia

HAEMODIALYSIS

E-P 051 The dependence of compliance on the cognitive functions of patients on chronic haemodialysisR. Arslanova1, I. Bastrykina1, O. Portnova2, M. T. Parisotto3

1Fresenius Medical Care, Fresenius NephroCare Dialysis Centre, Volgograd, Russian Federation; 2Fresenius Medical Care, Fresenius NephroCare department, Moscow, Russian Federation; 3Fresenius Medical Care, Care Value Management, Bad Homburg, Germany

E-P 052 Prevalence of obesity and evaluation of adequacy among this population during last 5 yearsV. IonitaHemodialysis, Fresenius NephroCare, Bucharest, Romania

26

E-P 053 Synthetic vascular graft an alternative to arteriovenous fistulaA. NeculaHemodialysis, Fresenius NephroCare, Bucharest, Romania

E-P 054 The challenging journey of pregnancy and dialysis: Challenge for patient and staffR. Naim, Z. Gavish, I. Bogner, I. Rafaelov-Atias, J. PlotkinNephrology, Rambam – Health Care Campus, Haifa, Israel

E-P 055 “Give light and people will find the way-” spiritual support for dialysis patientsR. Dahan, Z. Gavish, E. Kruzel-DavilaNephrology, Rambam-Health Care Campus, Haifa, Israel

E-P 056 Centered pproach – dialysis patient to Type 1 diabetes with eating disorders, anxiety and depression

G. MaximovHemodialysis Unit. Nephrology., Sheba (Tel Hashomer) Medical Center, Ramat Gan., Israel

E-P 057 HemoControl resolving intra dialysis hypotensionM. Drazeta, Z. ObricHemodialysis, Clinical hospital centre Zemun – Belgrade, Zemun, Serbia

E-P 058 Pregnancy in women on hemodialysisI. MahamidNehrology, Nephrolife, Tel Aviv Medical Centre, Umm el Fahem, Israel

E-P 060 Comparison of self-care ability and life satisfaction of patients receving dialysis and healthy individuals

C. Dogan1, A. Karakoc1, F. Turan1, A. Ozturk1, D. Ates1, F. Semercı2, M. Yılmaz1, N. O. Harmankaya1

1Dr.Sadı Konuk Traınıng and Research Hospıtal, Istanbul, Turkey; 2Medıkare Dıalysıs Center, Istanbul, Turkey

E-P 061 Choosing a treatment for kidney failureS. StiperskiNefrology, KBC Zagreb, Zagreb, Croatia

E-P 062 Change in compliance in a pregnant patient on chronic dialysis program. A case report

Z. É. Nagy, B. Thomas, J. Mátyus, J. Balla, V. BatthányDialysis Centre, Fresenius Medical Care, Debrecen, Hungary

E-P 064 Role of blood pressure monitoring to determine optimal body weight of hyperhydrated acute patientsE. Pintér, S. KeresztesiDialysis Centre, Fresenius Medical Care, Kecskemét, Hungary

E-P 103 Comparison of self-care ability and life satisfaction in patients receiving dialysisC. Dogan1, A. Karakoc1, F. Turan1, A. Ozturk1, D. Ates1, F. Semercı2, M. Yılmaz1, N. O. Harmankaya1

1Dr. Sadı Konuk Traınıng and Research Hospıtal, Istanbul, Turkey; 2Medıkare Dıalysıs Center, Istanbul, Turkey

HOME THERAPIES

E-P 065 Why and how often need hospital based hemodialysis session the home hemodialysis patients?A. Marti, D. Gacho, B. Lazaro, A. Bonilla, J. GonzalezNephrology, Consorcio Hospital General Univesitario Valencia, Valencia, Spain

E-P 104 The Journey Home: Growing a home hemodialysis program while fostering professional relationshipsK. Brown, K. ClarkeHome Hemodialysis, Peterborough Regional Health Centre, Peterborough, Ontario, Canada

27

MULTIMORBIDITY IN RENAL CARE

E-P 067 Analysis of lethal outcomes in patients on RRT and the identification of risk factorsI. Budakova1, O. Portnova2, M. T. Parisotto3

1Fresenius Medical Care, Fresenius NephroCare Dialysis Centre, Stary Oskol, Russian Federation; 2Fresenius Medical Care, Fresenius NephroCare department, Moscow, Russian Federation; 3Fresenius Medical Care, Care Value Management EMEA, Bad Homburg, Germany

NUTRITION

E-P 072 A kitchen „renal dietary” course for chronic kidney disease patients and quality nutrition supportL. Góz, B. Thomas, J. BallaDialysis Centre, Fresenius Medical Care, Debrecen, Hungary

OPEN FORUM

E-P 073 Human resource management of renal nursing staff: The case study of Northern GreeceS. Vovlianou1, N. Nikiforidou1, S. Zekaki2, E. Dimitriadis3

1Renal Unit, General Hospital of Kavala, Kavala, Greece; 2Director of Nursing Service, General Hospital of Kavala, Kavala, Greece; 3President of the Nursing Department, Eastern Macedonia and Thrace Institute of Technology, Kavala, Greece

E-P 074 Fibromuscular displasia – case reportM. Mihalić, Ž. DikaDivision of Nephrology, Arterial Hypertension, University Hospital Centre Zagreb, Zagreb, Croatia

E-P 075 Treatment of West Nile Fever virus infection by plasmapheresisM. Németh, I. Papp, J. BallaDialysis Centre, Fresenius Medical Care, Debrecen, Hungary

E-P 076 Haemodialysis and peritoneal dialysis from nursing aspect. Difficulties and differences due to experienceF. Gerhák, S. KeresztesiDialysis Centre, Fresenius Medical Care, Kecskemét, Hungary

PEADIATRIC RENAL CARE

E-P 077 Successful treatment of hyperlipidemia with plasmapheresis – case reportS. BesedicReferal Center for nephrology, dialysis and transplantation, University Hospital Center Zagreb, Zagreb, Croatia

PERITONEAL DIALYSIS

E-P 078 Dramatic and symptomatic decline in renal function – rapid start peritoneal dialysis (PD)?K. Dailey, S. Morgan, K. Wong, J. UyRenal Medicine, Royal Prince Alfred Hospital, Sydney, Australia

E-P 079 Anthropoplicometric measurements in peritoneal dialysis patientsC. Sayan1, L. Yucel1, Y. Deligoz Bildaci2, A. S. Artan2, O. C. Elcıoglu2, E. Haziyev2, M. Gursu2, R. Kazancioglu2

1Hemodialysis and Peritoneal Dialysis Unit, Bezmialem Vakif University Medical Faculty, Istanbul, Turkey; 2Nephrology, Bezmialem Vakif University Medical Faculty, Istanbul, Turkey

E-P 080 The effect of peritoneal dialysis on balance and falling riskD. D. Balci1, D. Efeyurtlu1, A. Inci2, S. Gul2, A. M. Sarikaya2, M. Bilgilisoy Filiz3, S. Koldas Dogan3, F. Sari4

1Peritoneal Dialysis, Health Sciences University Antalya Training and Research Hospital, Antalya, Turkey; 2Nephrology, Health Sciences University Antalya Training and Research Hospital, Antalya, Turkey; 3Physical Therapy and Rehabilitation, Health Sciences University Antalya Training and Research Hospital, Antalya, Turkey; 4Nephrology, Akdeniz University Medical School Hospital, Antalya, Turkey

28

E-P 082 Patients with high body mass index in peritoneal dialysis programT. Vargáné Szabó, S. KeresztesiDialysis Centre, Fresenius Medical Care, Kecskemét, Hungary

E-P 083 Does the fast peritoneal equilibration test replace the standart peritoneal equilibration test?A. Ozturk, D. Ulu, A. Karakoc, F. Turan, N. O. Harmankaya, M. Yılmaz, F. Kocak, A. OzdemırDr. Sadi Kouk Training and Research Hospital, Istanbul, Turkey

RISK MANAGEMENT & QUALITY IMPROVEMENT

E-P 084 Nephrological nurses and occupational exposure – how? when? why?A. Trzcińska1,2,3

1Medical University of Silesia, Katowice, Poland; 2Polish Nephrology Nurses Association, Katowice, Poland; 3Polish Vascular Access Club, Katowice, Poland

E-P 085 Quality management system in a haemodialysis unit and patient satisfactionA. Kavalieratou, G. GarofyllouHaemodialysis Unit, Konstantopoulio G.H. N. Ionia, Athens, Greece

E-P 086 Less is more – quality improvement through simplificationK. Dailey, D. DavisonDepartment of Renal Medicine, Royal Prince Alfred Hospital, Sydney, Australia

E-P 087 Introducing a falls risk assessment tool within the satellite haemodialysis unit settingG. Cater, N. Beddows, G. Dewsnap, N. Ward, C. PooleFresenius Medical Care Renal Services Ltd, Kings Norton, Birmingham, United Kingdom

E-P 088 Improving correct hand hygiene compliance in dialysis unitR. HaisHemodialysis, Assuta medical center, Haifa, Israel

E-P 091 Smart software application used in dialysis clinics – Workforce ManagementC. Popescu, M. PredaMedical, Fresenius Medical Care Romania, Bucharest, Romania

THE PATIENT EXPERIENCE

E-P 092 Travelling and HaemodialysisA. Kavalieratou, G. GarofyllouHaemodialysis Unit, Konstantopoulio G.H. N. Ionia, Athens, Greece

E-P 093 Is dialysis adequacy the determinant factor for the successful assessment of a treatment?V. Zoi, N. Piliouras, A. Maniati, D. Siopi, V. MarinopoulouDialysis Unit, ATTIKON University Hospital, Haidari, Athens, Greece

E-P 094 The conscious decision of haemodialysis discontinuation in elderly and the nurse’s aspectV. Zoi, N. PIliouras, M. Flevotomou, E. Bathra, V. Kiriakidis, V. MarinopoulouDialysis Unit, ATTIKON University Hospital, Haidari, Athens, Greece

TRANSPLANTATION

E-P 095 National transplant program in MontenegroD. Pelicic1, 2, M. Ratkovic3, 2, D. Radinovic3, B. J. Nikolina4, 5

1Center for Science, Clinical Center of Montenegro, Podgorica, Montenegro; 2Faculty of Medicine, University of Montenegro, Podgorica, Montenegro; 3Clinic for Nephrology, Clinical center of Montenegro, Podgorica, Montenegro; 4Department of nephrology, arterial hypertension, dialysis and transplantation, University Hospital Centre Zagreb, Zagreb, Croatia; 5School of Medicine, University of Zagreb, Zagreb, Croatia

29

E-P 096 Kidney transplant – a case study and dilemmas. What is right and what is wrong?I. Rafaelov Atias, M. Shem Tov Alisha, Z. Gavish, R. AsulinNephrology, Rambam-Health Care Campus, Haifa, Israel

E-P 097 Assessment of health-related quality of life in kidney transplant recipients vs dialysis patientsV. Koutlas1, M. Ikonomou2, E. Tzalavra1, Z. Delimitsou2, C. Pappas2, M. Mitsis1, E. Dounousi2

1Department of Surgery – Kidney Transplant Unit, University Hospital of Ioannina, Ioannina, Greece; 2Department of Nephrology, University Hospital of Ioannina, Ioannina, Greece

E-P 098 Dental care in dialysis and transplant patientsH. Klaric, Ž. Lubina, Ž. LubinaUniversity Hospital Zagreb, Zagreb, Croatia, Department for Nephrology, AH, Dialysis and Transplantion, Zagreb, Croatia

VASCULAR ACCESS

E-P 099 From the creation of a new AVF to full performances, our experienceG. Radakovic, S. JandricInternational Dialysis Centre Banja Luka, Fresenius Medical Care Bosnia and Herzegovina, Banja Luka, Bosnia and Herzegovina

E-P 101 Assessment of the knowledge hemodialysis patients have of the arteriovenous fistula and its careM. Lukoševičienė, J. KristopaitieneB|Braun Avitum, Vilnius, Lithuania

E-P 102 Applying of rope ladder puncture technique in our dialysis networkR. Mogyorósi, K. HohmannDialysis Centre Ltd., Fresenius Medical Care, Budapest, Hungary

30

THE EXHIBITION FLOOR PLAN

List of Exhibitors1a Fresenius Medical Care1b Fresenius Medical Care2 B.Braun3 Medtronic4 IHT – Innovative Health

Technologies

5 Open area6 NxStage7 Diaverum8 Tauropharm9 Physidia10 Diasoft

11 Emodial12 EDTNA/ERCA13 Medow14 Peripal

31

THE EXHIBITORSB. Braun Avitum AGA family-owned company founded in 1839 in Melsungen, Germany, B. Braun today is one of the world‘s leading healthcare companies with more than 63,000 employees working in 64 countries. The product range includes dialysis machines and dialysis consumables for chronic dialysis and acute dialysis. In addition to its role as a manufacturer of dialysis equipment, B. Braun is also an important provider of dialysis treatment. B. Braun operates more than 370 renal care centers. Additional care services such as holiday dialysis and pre-dialysis programs are offered in most markets.

Address: Am Buschberg 1, Melsungen, Hessen, 34212, GermanyContact Person: Vanessa HoehleWebsite: www.bbraun-dialysis.com

DiasoftMISSION – Our mission is to develop a patient care IT system for renal patients. In order to increase the quality of treatment and out of respect for each individual human being, Diasoft created and maintains a safe medical device. CORE VALUES – Respect for each individual | Focus on safety and privacy | Professional and independent in handling data | Dedicated to improve the quality of treatment | Easy to approach. QUALITY – Diasoft meets the medical requirements and safety standards and is a CE marked medical device. To guarantee the highest level of safety for the patient and the user, the software Diamant is classied as a Class II B device. This guarantees the highest level of patient safety. Diasoft has a certied Quality Management System compliant with ISO 13485:2016 and ISO 9001:2015 and an integrated Information Security Management System conform ISO 27001:2013.

Address: Klepelhoek 11, Leusden, Netherlands, 3833 GZContact person: Nicole van RooijenWebsite: https://diasoft.nl/

DIAVERUMDiaverum is Europe’s largest product-independent renal care service providers and one of the world leaders in this ’ experience in the area of dialysis. The high focus on medical quality, care management and the treatment of kidney disease, as well as its individual patient care focus, makes Diaverum unique. Today, 11,000 employees care for more than 36,000 patients in 20 countries in its 380 centres located in Europe, South America, Africa and Asia. Diaverum has its roots in Sweden. For further information, please visit our website: www.diaverum.com

Address: Hyllie Boulevard 39, Malmö, SE 215 37, SwedenContact Person: Michaela BlomstrandWebsite: www.Diaverum.com

32

EMODIALSince its foundation, Emodial has been committed to develop what we call the “therapeutical alliance”, a model based on the direct cooperation between the main actors of the vascular access scenario: doctors, nurses, patients, patients associations, caregivers. Starting from the direct experience of patients, which Emodial collects through dialogue with them and with patient associations, the aim is to create solutions to accomplish its mission and its promise: improve the patient‘s quality of life, raise healthcare standards, contain and optimize healthcare spending and reduce healthcare time and risks associated with it. Emodial develops advanced solutions for the vascular access management in hemodialysis, oncology, intensive care and parenteral nutrition: the Silver line of pads, plasters and pockets for CVCs, peritoneal catheters and PICCs releasing silver ions with antibacterial and anti-in pockets for catheter, for bath and shower.

Address: VIA G. FINATI 4/A, Ferrara, 44124, ItalyContact Person: Patrizia CozzolinoWebsite: www.emodial.it

Fresenius Medical Care Deutschland GmbHFresenius Medical Care is the world’s leading provider of products and services for people with chronic kidney failure. We care for more than 336,000 patients in our global network of more than 3,900 dialysis clinics. At the same time, we operate 42 production sites on all continents, to provide dialysis products such as dialysis machines, dialyzers and related disposables. Along with this core business, Fresenius Medical Care provides related medical services in the Creating a future worth living. For patients. Worldwide. Every day. This vision guides us in our efforts to give our patients around the world a better life by offering them high-quality products and outstanding health care. In NephroCare, the international dialysis care provider network of Fresenius Medical Care, we developed our recipe for success to deliver value in renal care, for patients and for healthcare systems.

Address: Else-Kröner-Str. 1, Bad Homburg v.d.H., 61352, GermanyContact Person: Kerstin BeyerWebsite: www.freseniusmedicalcare.com

Innovative Health TechnologiesIHT (Iberhospitex, S.A.) is a European company, based in Barcelona, with over 38 years of experience in healthcare technologies (1980–2018). We market our products worldwide. Our aim is to continue manufacturing high quality products, focusing particularly on dressings for wound treatment and skin care (Skin & Wound Care Business Unit) and less invasive treatment for cardiovascular disease (Cordynamic Business Unit).

Address: Avinguda Catalunya, 4, Lliçà de Vall, Barcelona, 08185, SpainContact Person: Dolors Cañete de CárdenasWebsite: www.iht.es

33

MEDOWMedow develops innovative health care products that bring eciency, comfort and joy by using design and colour. Our aim is to create a better health care by finding the small problems where our solutions will make a big difference. Medow’s first product IV-bracelet, is an easy to use bracelet to which blood lines can be attached to keep them and needles in place during dialysis treatments. The bracelet gives the patients a safe and comfortable treatment and at the same time eases the nurses’ work.

Address: Revingegatan 15 A, Lund, 22356, SwedenContact Person: Frida McCabeWebsite: https://medow.se/

MedtronicAs a global leader in medical technology, services and solutions, Medtronic improves the health and lives of millions of people each year. We believe our deep clinical, therapeutic and economic expertise can help address the complex challenges — such as rising costs, aging populations and the burden of chronic disease – faced by families and healthcare systems today. But, we cant do it alone. That’s why we’re committed to partnering in new ways and developing powerful solutions that deliver better patient outcomes. Founded in 1949 as a medical repair company, we’re now among the world’s largest medical technology, services and solutions companies, employing more than 85,000 people worldwide, serving physicians, hospitals and patients in more than 160 countries. Join us in our commitment to take healthcare Further, Together. Learn more at Medtronic.com.

Contact Person: Andrea FuskovaWebsite: Medtronic.eu

NxStage Medical, Inc.NxStage Medical, Inc. is a leading medical technology company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of end-stage renal disease (ESRD) and acute kidney failure. NxStage also has established a small number of dialysis clinics committed to the development of innovative care delivery models for patients with ESRD.

Address: 350 Merrimack Street, Lawrence, MA 01843Contact Person: Colleen MooreWebsite: www.nxstage.com

Peripal AGPeripal AG is a privately funded start-up from the ETH Zürich and the medtech industry. It‘s CE-marked innovation PeriSafe® is available for patients in EU countries and can help them to perform their daily peritoneal dialysis daily therapy at home. It guides the catheter connection without manual contact with the dialysis tubing and enables more patients to receive their therapy at home. Compared to hospital-based treatment, this would result in considerable healthcare cost reductions worldwide.

Address: Limmatquai 112, Zürich, 8001, SwitzerlandContact Person: Martin DubachWebsite: www.peripal.com

http://www.peripal.com

34

PhysidiaPhysidia is a French company created in 2010, with an expertise in the development, manufacturing and distribution of innovative technology for daily home dialysis. Physidia is present today in 16 countries, operating directly in France and The United Kingdom and through distributor partners in the rest of Europe. Physidia’s innovations are based on several technological breaking points, offering a robust, portable and connected device, whilst ensuring a performing treatment in total autonomy. Created by an expert team, Physidia S3 monitor has been specifically developed to respond to the needs of simplicity and safety of ESRD patients in home hemodialysis.

Address: 11–13, bd. des Bretonnières, Saint-Barthélémy d’Anjou, 49124, FranceContact Person: Veliana TodorovaWebsite: www.physidia.fr

TauroPharm GmbHTauroPharm GmbH is a life science company specialized in antimicrobial medical devices. One of the company’s core interests is to offer a safe and effective technology for locking central venous access devices (catheters and ports). TauroLock™, a non-antibiotic lock solution, which is capable of dramatically reducing catheter related blood stream infections (CRBSI) is free of side-effects. The active compound is taurolidine which is not an antibiotic, but a derivative of an amino acid. TauroLock™ is highly effective in eradicating bacteria and fungi and has been successfully tested on more than five hundred organisms, including multi resistant forms such as MRSA and VRE. It is to be used in dialysis, oncology, intensive careand parenteral nutrition. To improve catheter patency TauroLock™ products contain 4% citrate and in addition heparin or urokinase.

Address: August-Bebel-Str. 51, Waldbüttelbrunn, 97297, GermanyContact Person: Kerstin BachmannWebsite: www.taurolock.com

The organizers would like to express their thanks to Prague for it’s support

http://www.physidia.fr

35

36

PRACTICAL CONFERENCE INFORMATIONConference Badges Each Conference delegate will receive a Conference badge upon registration. The Conference badge must be worn during the entire Conference to be able to enter the Scientific Sessions and receive education accreditation. On your badge there is a barcode which will be scanned when entering and leaving each session hall.

Credits will be assigned according to the information received from the barcode system. This information is also used for safety reasons to register participants who are in the building in case of emergency. Therefore, it is important you present your badge at each session hall.

48th EDTNA/ERCA Interna onal ConferencePrague, Czech RepublicSeptember 14th-17th, 2019

ENTRANCE EXIT

DELEGATE


ENTRANCE EXIT

DELEGATE


VOLUNTEER ACCOMPANY PERSON


STAFF


HOSTESS


SET�UP CREW


DISMANTLING CREW


EXHIBITOR


PRESS


GUEST


ENTRANCE EXIT

GUEST SPEAKER

Coffee BreaksCoffee & tea will be provided during breaks. Lunch boxes will be provided on Sunday, September 15th and Monday, September 16th

at lunch time breaks.

Internet WiFi is free of charge, no password neededNetwork: EDTNA/ERCA_CUBEX

Insurance The Conference organizer cannot accept liability for personal injuries sustained or for loss or damage of property belonging to Conference participants, either during or as a result of the Conference. Please check the validity of your own insurance.

Conference Language The Conference is being organized by an International Association with the goal of Education and Science. All oral presentations and posters must be in English. Special sessions might be organized in languages other than English and without translation. All hostesses and Conference staff speak English and other languages.

Sessions held in the main hall will be simultaneously translated from English into Czech.

The Team of EDTNA/ERCA Our Team from the Secretariat, Membership & Conference Department will be available at the Registration Desk and in the EDTNA/ERCA booth to support you during the entire Conference.

PostersE-Poster Stations are located on the 1st floor in the Exhibition Area.

37

Photo and Video Participants are kindly reminded that taking photos and videos is prohibited at all oral presentations to reduce disruption for speakers and the audience. Delegates, exhibitors, sponsors, speakers and any other registered attendees of the 48th EDTNA/ERCA International Conference, Prague, Czech Republic, September 14th–17th, 2019 acknowledge the information that pictures, videos and sound documents are taken during the Conference on behalf of EDTNA/ERCA (Organizer), and may be stored, used or published for Conference Reports and/or future information to members and interested renal community. It shall be clear to attendees that photographs, sound or video recordings taken during the conference will include recognizable images or voices of those in attendance and that such material may be made available on the Associations website or may be posted in Social Media communicating about the Conference. As EDTNA/ERCA we do not prohibit participants, exhibitors, sponsors or media from photographing, video- or audio-taping some Conference activities. EDTNA/ERCA is not responsible for third party use of such materials. Any individual has the right to deny participation in photographs, video or audio recordings. A person always has the right to revoke any consent given for use and may ask to get complete information on such personal data filed and stored and can ask that audio-visual data on the person is deleted. The ownership remains at all times with the person on pictures or on voice or video recorded material.

https://www.edtnaerca.org/resource/edtna/files/General_Terms_and_Conditions.pdf

REGISTRATION FEES – ONSITE

CategoryEUR Net of VAT

EUR VAT 21 %**

EUR Total incl. VAT 21 %

Member *** 471,07 98,93 570,00

Non-member 574,38 120,62 695,00

Student* 223,14 46,86 270,00

Student Fee* for MEMBERS 123,96 26,04 150,00

Note: * Student fee is applicable until the age of 26 years; students shall submit a document of their school or university proving the age and student status when they register.** Participant fees are subject to 21% of Czech VAT, payable as NET plus VAT. EDTNA/ERCA VAT registration is in process; taxable invoices are made after April 1st, 2019 only. *** Members may not apply for the Member Participant Fee if they are not a current member. To become a member, register here: EDTNA/ERCA General member registration form. After July 15th a registration as NEW member is not possible.*** Global Members shall register at the Member Participant Fee; Conference Members 2018 shall register at the Non-Member Fee.

https://www.edtnaerca.org/resource/edtna/files/General_Terms_and_Conditions.pdf

https://www.edtnaerca.org/membership/how-to-join

38

OPENING HOURS SUMMARYRegistrationAll documents, personal name badge and Conference bag will be handed out to registered participants during the following opening hours

SATURDAY, September 14th, 2019 08:00–20:00

SUNDAY, September 15th, 2019 08:00–18:00

MONDAY, September 16th, 2019 08:00–18:00

TUESDAY, September 17th, 2019 08:00–14:00

Speakers’ Ready Room




TUESDAY, September 17th, 2019 07:30–13:00

Exhibition




GOOD TO KNOW ABOUT PRAGUEMore information about Prague can be find on https://www.prague.eu/en/practical orhttps://www.edtnaerca.org/resource/edtna/files/EDTNA_ERCA_2nd_Announcement_Prague_2019.pdf

https://www.prague.eu/en/practical

https://www.edtnaerca.org/resource/edtna/files/EDTNA_ERCA_2nd_Announcement_Prague_2019.pdf

39

CONFERENCE CONTACTSEDTNA/ERCA Secretariat & Membership Management Högs Byväg 118 SE-246 55 Löddeköpinge Sweden Phone: + 46 46 70 96 24 E-mail: [email protected]

EDTNA/ERCA Conference, Marketing, Industry Relations, Exhibition & Sponsorship Mrs. Anki Davidson Marketing Director P&B – Presentation & Branding AB Källstorps Gård Högs Byväg 118 S-246 55 Löddeköpinge Sweden Phone: +46 46 70 96 24Mobile: +46 721 94 00 10 E-mail: [email protected]

EDTNA/ERCA Conference Department & Registrations GUARANT International spol. s r.o. Na Pankráci 17 CZ-140 21 Prague 4 Czech Republic Phone: +420 284 00 14 44 Fax: +420 284 00 14 48 E-mail: [email protected]

EDTNA/ERCA Head Office Seestrasse 91, CH 6052, Hergiswil, Switzerland, UID CHE 498.689.154

JURISDICTION The place of jurisdiction is Stans, Switzerland

mailto:[email protected]

mailto:[email protected]

PRESIDENTS MESSAGEIt is with great pleasure and pride that we invite you to join us in Ljubljana where our 49th EDTNA/ERCAInternational Conference, September 12th - 15th, 2020 will take place. Ljubljana is Slovenia’s capital andlargest city and it’s known for its university population and green spaces.

The EDTNA/ERCA is a multidisciplinary organization for those working in renal care. Through the Scientific Programme we offer a significant and valuable contribution to the care by Workshops, Courses and Educational Sessions. The Conference is a forum for sharing best research and innovations in practice and helps initiating and promoting quality renal research and practice around the world. It also has an important role of educating, exchanging information and experience, utilizing the expertise of healthcare professionals, service leaders, academics, researchers, care givers, people with renal disease and industry partners. Delegates from around 70 countries, who come together to share experience, innovations and knowledge.

We are very much looking forward to Welcoming you to Ljubljana!With warm regards,

Edita NoruišienėEDTNA/ERCA President

49th EDTNA/ERCA International ConferenceSeptember 12th - 15th, 2020 Ljubljana, Slovenia

Conference ThemeKnowledge, Skills & Commitment - Core Elements to Manage Care

Abstract Submission deadline - January 17th, 2020

www.edtnaerca.org/conferences

Documents

Final Programme - edtnaerca.org · Cannulation Devices across Europe and its Implications – The final result of an international Survey A joint project between EDTNA/ERCA & Medtronic